Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey

The Lancet

Volumn 373, Issue 9668, 2009, Pages 1025-1032

  Lowther, Sara A ^a   Curriero, Frank C ^a,b   Kalish, Brian T ^a   Shields, Timothy M ^a   Monze, Mwaka ^c   Moss, William J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Johns Hopkins University   (United States)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MEASLE VIRUS ANTIBODY; MEASLES VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ARTICLE; CHILD; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; ZAMBIA;

EID: 62349088643     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60142-2     Document Type: Article

References (33)

1. Wolfson L.J., Strebel P.M., Gacic-Dobo M., Hoekstra E.J., McFarland J.W., and Hersh B.S. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 369 (2007) 191-200
2. WHO, United Nations Children's Fund. Measles mortality reduction and regional elimination strategic plan 2001-2005 (2001), World Health Organization, Geneva, Switzerland
3. CDC. Progress in global measles control and mortality reduction, 2000-2006. MMWR Morb Mortal Wkly Rep 56 (2007) 1237-1241
4. WHO, United Nations Children's Fund. Global Immunization Vision and Strategy 2006-2015 (2005), World Health Organization, Geneva, Switzerland
5. Orenstein W.A., Strebel P.M., Papania M., Sutter R.W., Bellini W.J., and Cochi S.L. Measles eradication: is it in our future?. Am J Public Health 90 (2000) 1521-1525
6. Enquselassie F., Ayele W., Dejene A., et al. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination. Epidemiol Infect 130 (2003) 507-519
7. Ray S.K., Mallik S., Munsi A.K., Mitra S.P., Baur B., and Kumar S. Epidemiological study of measles in slum areas of Kolkata. Indian J Pediatr 71 (2004) 583-586
8. Kleinschmidt I., Pettifor A., Morris N., Macphail C., and Rees H. Geographic distribution of human immunodeficiency virus in South Africa. Am J Trop Med Hyg 77 (2007) 1163-1169
9. Grais R.F., Ferrari M.J., Dubray C., et al. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention. Trans R Soc Trop Med Hyg 100 (2006) 867-873
10. CDC. Progress in measles control-Zambia, 1999-2004. MMWR Morb Mortal Wkly Rep 54 (2005) 581-584
11. Huber P.J. The behavior of maximum likelihood estimates under nonstandard conditions. Proceedings of the Fifth Berkley Symposium on Mathematical Statistics and Probability 1 (1967), University of California Press, Berkeley, CA 221-223
12. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48 (1980) 817-830
13. Froot K.A. Consistent covariance matrix estimation with cross-sectional dependence and heteroskedasticity in financial data. J Financial Quant Anal 24 (1989) 333-355
14. Cressie N.A. Statistics for spatial data (1993), John Wiley & Sons Inc, New Jersey
15. Diggle P.J. Statistical analysis of spatial point patterns (2006), Academic Press, New York
16. Waller L.A., and Gotway C.A. Applied spatial statistics for public health data (2004), John Wiley & Sons Inc, New Jersey
17. WHO. Immunization surveillance, assessment and monitoring. Zambia reported cases. http://www.who.int/vaccines/globalsummary/immunization/timeseries/tsincidencebycountrycfm?country=Zambia (accessed Dec 20, 2007).
18. WHO. Recommendations from an ad hoc meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on the use of alternative diagnostic samples for measles and rubella surveillance. MMWR Morb Mortal Wkly Rep 57 (2008) 657-660
19. Lowther S.A., Curriero F.C., Shields T., Ahmed S., Monze M., and Moss W.J. Feasibility of satellite image-based sampling for a health survey among urban townships of Lusaka, Zambia. Trop Med Int Health 14 (2009) 70-78
20. Muller C.P., Kremer J.R., Best J.M., Dourado I., Triki H., and Reef S. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005. Vaccine 25 (2007) 1-9
21. Moss W.J., Scott S., Mugala N., et al. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis 196 (2007) 347-355
22. Helfand R.F., Moss W.J., Harpaz R., Scott S., and Cutts F. Evaluating the impact of the HIV pandemic on measles control and elimination. Bull World Health Organ 83 (2005) 329-337
23. Scott S., Mossong J., Moss W.J., Cutts F.T., and Cousens S. Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model. Int J Epidemiol 37 (2008) 356-367
24. Setse R.W., Cutts F., Monze M., et al. HIV-1 infection as a risk factor for incomplete childhood immunization in Zambia. J Trop Pediatr 52 (2006) 324-328
25. Parker A.A., Staggs W., Dayan G.H., et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 355 (2006) 447-455
26. CDC. Outbreak of measles-San Diego, California, January-February 2008. MMWR Morb Mortal Wkly Rep 57 (2008) 203-206
27. van den Hof S., Meffre C.M., Conyn-van Spaendonck M.A., Woonink F., de Melker H.E., and van Binnendijk R.S. Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerg Infect Dis 7 suppl 3 (2001) 593-597
28. CDC. Measles epidemic attributed to inadequate vaccination coverage-Campania, Italy, 2002. MMWR Morb Mortal Wkly Rep 52 (2003) 1044-1047
29. Helfand R.F., Chibi T., Biellik R., Shearly A., and Bellini W.J. Negative impact of clinical misdiagnosis of measles on health workers' confidence in measles vaccine. Epidemiol Infect 132 (2003) 7-10
30. Kremer J.R., and Muller C.P. Evaluation of commercial assay detecting specific immunoglobulin G in oral fluid for determining measles immunity in vaccinees. Clin Diagn Lab Immunol 12 (2005) 668-670
31. Nokes D.J., Enquselassie F., Nigatu W., et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 79 (2001) 588-595
32. Nigatu W., Samuel D., Cohen B., et al. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid surveys. Vaccine 26 (2008) 4769-4774
33. Ohuma E.O., Okiro E.A., Bett A., et al. Evaluation of a measles campaign by oral-fluid survey in a rural Kenyan district: interpretation of antibody prevalence data using mixture models. Epidemiol Infect 137 (2009) 227-233